[Focusing on issues about phacoemulsification lens extraction combined with goniosynechialysis]
1Department of Ophthalmology & Visual Science, Shanghai Medical College of Fudan University, Department of Ophthalmology, Eye & ENT Hospital of Fudan University, NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai 200031, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 13, 2024
Summary
Goniosynechialysis combined with phacoemulsification surgery effectively treats primary angle-closure glaucoma by restoring aqueous outflow. This review highlights key considerations for optimizing this combined surgical approach.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Innovation
Context:
- Primary angle-closure glaucoma (PACG) involves angle closure, a core pathological process.
- Goniosynechialysis addresses the root cause of PACG by reconstructing the aqueous outflow pathway, unlike filtration surgery.
- Combined phacoemulsification with goniosynechialysis has gained significant clinical attention for PACG treatment over the last decade.
Purpose:
- To review the clinical practice of combining phacoemulsification lens extraction with goniosynechialysis for primary angle-closure glaucoma.
- To identify critical aspects for successful clinical application of this combined surgical technique.
- To provide guidance on optimizing outcomes and preventing complications associated with goniosynechialysis in PACG.
Summary:
- Phacoemulsification with posterior chamber intraocular lens implantation combined with goniosynechialysis is a key treatment for primary angle-closure glaucoma.
- This article examines the interplay between phacoemulsification and goniosynechialysis, surgical effectiveness, influencing factors, and strategies to prevent postoperative synechiae.
- Focus is placed on improving the application of goniosynechialysis for better patient outcomes in angle-closure glaucoma.
Impact:
- Offers practical insights for ophthalmic surgeons performing combined procedures for PACG.
- Aims to enhance the effectiveness of goniosynechialysis by addressing potential challenges and influencing factors.
- Contributes to the ongoing clinical research and discussion surrounding surgical management of primary angle-closure glaucoma.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
453
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
453
01:25Glaucoma: Overview
528
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
528
01:27Open Angle Glaucoma: Treatment
407
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
407